November 18, 2016 - By Darrin Black · 0 Comments
Nov 18 is a negative day so far for iShares US Pharmaceuticals (NYSEARCA:IHE) as the ETF is active during the day after losing 0.83% to hit $145.1 per share. The exchange traded fund has 685.20M net assets and 1.90% volatility this month.
Over the course of the day 4,949 shares traded hands, as compared to an average volume of 34,830 over the last 30 days for iShares US Pharmaceuticals (NYSEARCA:IHE).
The ETF is -9.33% of its 52-Week High and 15.15% of its low, and is currently having ATR of 3.42. This year’s performance is -7.77% while this quarter’s performance is -4.57%.
The ETF’s YTD performance is -15.07%, the 1 year is -10.71% and the 3 year is 9.38%.
The ETF’s average P/E ratio is 20.39, the price to book is 1.81, the price to sales is 3.23 and the price to cashflow is 12.98. It was started on 05/05/2006. The fund’s top holdings are: Johnson & Johnson Common Stock for 10.31% of assets, Pfizer Inc. Common Stock for 8.34%, Merck & Company Inc. Common St for 8.01%, Bristol-Myers Squibb Company Co for 6.27%, Allergan plc Ordinary Shares for 6.11%, Eli Lilly and Company Common St for 6.09%, Zoetis Inc. Class A Common Stoc for 4.12%, Mylan N.V. for 3.63%, Perrigo Company plc Ordinary Sh for 3.26%, TESARO Inc. for 2.92%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as 1.02% yield.
More notable recent iShares Dow Jones US Pharm Indx (ETF) (NYSEARCA:IHE) news were published by: Thestreet.com which released: “Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios” on November 17, 2016, also Benzinga.com with their article: “Last Night’s Election – A Series Of Fortunate Events For Big Pharma” published on November 09, 2016, Benzinga.com published: “Getting Into The Drug Business: From NDAs To PDUFA Dates” on September 27, 2016. More interesting news about iShares Dow Jones US Pharm Indx (ETF) (NYSEARCA:IHE) were released by: Benzinga.com and their article: “Looking For ETF Dogs That Will Hunt” published on October 10, 2016 as well as Investorplace.com‘s news article titled: “BMY Stock: Don’t Try to Catch This Falling Knife … Yet” with publication date: October 17, 2016.
iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. The ETF has a market cap of $685.20 million. Pharmaceuticals Index Fund , is an exchange traded fund. It has a 4.51 P/E ratio. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Darrin Black